Browsing by Subject "Her2 positive"
Now showing items 1-1 of 1
-
Article
Trastuzumab beyond progression in HER2-positive advanced breast cancer: The Royal Marsden experience
(2011)BACKGROUND: Recent UK clinical guidance advises against continuing trastuzumab (T) beyond disease progression (PD) in the absence of brain metastases in patients with HER-2 positive (+ ve) advanced breast cancer. We have ...